- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Novocure, United Therapeutics and Kite Pharma were among the biotech stock movers in early trading Monday.
Credit Suisse initiated United Therapeutics with an 'underperform' rating.
Here are Monday's top research calls, including upgrades for FedEx, Garmin and HP, and a downgrade for GoPro.
Pharma stocks have bounced back from their prior selloff, but whether they will continue their upward trend under a Donald Trump administration remains unclear.